Preventing Drug Resistance Requires More Focus On Quality Medicines

American Enterprise Institute’s “AEIdeas”: More substandard medicines drive faster resistance
Roger Bate, an author and visiting scholar at the American Enterprise Institute, discusses how substandard-quality medicines contribute to drug resistance, using tuberculosis as an example. He writes, “If we’re going to win the global fight against TB, we need better oversight of TB medicine manufacturing and information on failing companies so physicians and patients can boycott certain manufacturers…” (10/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.